Lungs News and Research

RSS

Researchers find how KEAP1 tumor suppressor works

A tumor-suppressing protein snatches up an important cancer-promoting enzyme and tags it with molecules that condemn it to destruction, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports this week in the journal Molecular Cell.

12 Oct 2009

Findings may reveal new treatments for people suffering from chronic hemoglobin levels

A gene with a significant effect on regulating hemoglobin in the body has been identified as part of a genome-wide association study, which looked at the link between genes and hemoglobin level in 16,000 people.

12 Oct 2009

PPA bus tour to raise awareness of patient assistance programs

The 'Help is Here Express' bus tour will be stopping in Iowa, Southern Illinois, and Southern Indiana throughout the week of October 12 -- 16th at various cities in order to help uninsured and financially-struggling Midwesterners access information on programs that provide prescription medicines for free or nearly free.

12 Oct 2009

AACR to host its first Frontiers in Basic Cancer Research Meeting

The American Association for Cancer Research will host its first Frontiers in Basic Cancer Research Meeting in Boston from Oct. 8-11, 2009. The meeting is expected to draw nearly 500 leading scientists to present on high-profile topics like epigenetics, metastasis and systems biology, and create synergies among the many subfields of basic science.

12 Oct 2009

Bad breath can be treated

All of us have experienced bad breath at some point. However, suffering from chronic bad breath, or halitosis, can be embarrassing and affect your self-esteem and relationships with family, friends and coworkers. The good news -- bad breath is often preventable and easily treated.

12 Oct 2009

Eric Boerwinkle receives $26 million federal stimulus grant to identify genetic factors influencing common diseases

Eric Boerwinkle, Ph.D., a professor at The University of Texas Health Science Center at Houston, has received a $26 million federal stimulus grant to lead an effort to pinpoint genetic factors affecting the risk of heart, lung and blood diseases.

12 Oct 2009

Hyper-SAGE with MRI sensitivity, a promising tool for in vivo diagnostics and molecular imaging

A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.

12 Oct 2009

Presentations on efficacy of interferon to combat influenza

Amarillo Biosciences, Inc. (ABI) today announced that Professor Dr. Otto Haller from the Department of Virology, Freiburg University, Germany and Professor Dr. Oliver Planz from the Friedrich Loeffler Institute, Tubingen, Germany gave two separate presentations on the efficacy of interferon to combat influenza.

12 Oct 2009

NIH launches trial for the determination of 2009 H1N1 influenza vaccine for asthma patients

The National Institutes of Health is preparing to launch the first government-sponsored clinical trial to determine what dose of the 2009 H1N1 influenza vaccine is needed to induce a protective immune response in people with asthma, especially those with severe disease.

12 Oct 2009

Riley Hospital for Children commences patient enrollment in clinical trial of cystic fibrosis drug

The Riley Hospital for Children Cystic Fibrosis Center is the first site in the nation to enroll patients ages 6-11 for the first part of a 48-week clinical trial of a promising investigational treatment for cystic fibrosis (CF).

9 Oct 2009

A three-month study reveals the impact of swine flu on the health of the general public in Australia and New Zealand

A comprehensive study has revealed, for the first time, the impact of swine flu on the health of the general public in Australia and New Zealand.

9 Oct 2009

SCAA to host Survivor Celebration event to mark SCA Awareness Month

A nationwide gathering of sudden cardiac arrest (SCA) survivors will mark SCA Awareness Month with a Survivor Celebration on Friday, October 9th at 7 p.m. in Chicago. This survivor event, hosted by the Sudden Cardiac Arrest Association (SCAA) at the Hyatt Regency O’Hare, 9300 Bryn Mawr Avenue in Rosemont, is part of three-day program that will make up the organization’s annual meeting.

9 Oct 2009

Breathe Easy, Stay Healthy Campaign for reducing toxic air pollution in Pittsburgh

Today, Citizens for Pennsylvania’s Future (PennFuture), joined by leaders from the Group Against Smog and Pollution (GASP) and Clean Water Action, along with Dr. Evelyn O. Talbott of the University of Pittsburgh Graduate School of Public Health Department of Epidemiology and Allegheny County Council President Richard Fitzgerald, announced a major new campaign to reduce the fine soot pollution responsible for Pittsburgh’s number one ranking for dirtiest air for two years running.

9 Oct 2009

St. Petersburg City Council partners with American Lung Association for "Faces of Influenza" campaign

Mayor Rick Baker and members of St. Petersburg City Council are partnering with the American Lung Association in Florida Gulfcoast area on its Faces of Influenza educational initiative to kick off the 2009-2010 influenza season in Tampa/St. Petersburg.

9 Oct 2009

NHLBI grants for diagnosis and treatment of cardiovascular and blood disorders

Two teams led by Massachusetts General Hospital (MGH) researchers, also members of the Harvard Stem Cell Institute (HSCI), are among 18 groups receiving National Heart Lung and Blood Institute (NHLBI) grants for the development of stem-cell based tools and treatments to understand and treat cardiovascular and blood disorders.

9 Oct 2009

Researchers to develop new technique to detect tuberculosis in developing countries

Two billion people worldwide carry the pathogen that causes tuberculosis (TB), and most of them do not even know they are infected. This is because some 90 percent of people with TB have "latent" infections. They have no symptoms, they can't spread the disease to others and the bug remains dormant in their lungs -- often for years.

9 Oct 2009

NHLBI awards $16.7 million to develop new clinical strategies in stem cell therapy

The National Heart, Lung and Blood Institute has awarded a total of $16.7 million to Irwin Bernstein, M.D., and Beverly Torok-Storb, Ph.D., both members of the Clinical Research Division at Fred Hutchinson Cancer Research Center.

9 Oct 2009

NHLBI to hold Symposium to review latest findings in Cardiovascular Regenerative Medicine

With advancements in the field of stem cell research accelerating, the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) will hold its third Symposium on Cardiovascular Regenerative Medicine to review the latest findings in the field and examine future directions.

9 Oct 2009

New cancer drugs boost drug spending

Cancer treatments are on track to become the biggest driver of specialty pharmacy spending as its contribution to overall drug spending hit five percent for the first time in the first half of 2009, according to Medco Health Solutions, Inc.

8 Oct 2009

Aeolus Pharmaceuticals’ AEOL 10150 effective against mustard gas exposure

Aeolus Pharmaceuticals, Inc. reported that researchers from National Jewish Health and Lovelace Respiratory Research Institute have completed a series of preliminary studies demonstrating that AEOL 10150 protects lungs from whole mustard gas exposure in rats. Data were presented at the Regional CounterACT Countermeasures Against Chemical Threats Conference in Albuquerque, NM.

8 Oct 2009

Lungs News and Research

Researchers find how KEAP1 tumor suppressor works

Findings may reveal new treatments for people suffering from chronic hemoglobin levels

PPA bus tour to raise awareness of patient assistance programs

AACR to host its first Frontiers in Basic Cancer Research Meeting

Bad breath can be treated

Eric Boerwinkle receives $26 million federal stimulus grant to identify genetic factors influencing common diseases

Hyper-SAGE with MRI sensitivity, a promising tool for in vivo diagnostics and molecular imaging

Presentations on efficacy of interferon to combat influenza

NIH launches trial for the determination of 2009 H1N1 influenza vaccine for asthma patients

Riley Hospital for Children commences patient enrollment in clinical trial of cystic fibrosis drug

A three-month study reveals the impact of swine flu on the health of the general public in Australia and New Zealand

SCAA to host Survivor Celebration event to mark SCA Awareness Month

Breathe Easy, Stay Healthy Campaign for reducing toxic air pollution in Pittsburgh

St. Petersburg City Council partners with American Lung Association for "Faces of Influenza" campaign

NHLBI grants for diagnosis and treatment of cardiovascular and blood disorders

Researchers to develop new technique to detect tuberculosis in developing countries

NHLBI awards $16.7 million to develop new clinical strategies in stem cell therapy

NHLBI to hold Symposium to review latest findings in Cardiovascular Regenerative Medicine

New cancer drugs boost drug spending

Aeolus Pharmaceuticals’ AEOL 10150 effective against mustard gas exposure

The ultimate guide to lung research tools and protocols eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News